|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn893332893 |
003 |
OCoLC |
005 |
20231120111812.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
141018s2015 enka ob 001 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e rda
|e pn
|c EBLCP
|d N$T
|d GZM
|d YDXCP
|d OCLCO
|d UIU
|d OCLCQ
|d OCLCO
|d N$T
|d COO
|d TPH
|d DEBSZ
|d ITD
|d OCLCF
|d UAB
|d OCLCO
|d MERER
|d OCLCO
|d OCLCQ
|d VGM
|d OCLCO
|d OCLCQ
|d MERUC
|d D6H
|d OCLCO
|d OCLCQ
|d AU@
|d OCLCQ
|d UBY
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCA
|d DKU
|d OCLCO
|d OCLCQ
|d OCLCO
|
020 |
|
|
|a 9780123984906
|q (electronic bk.)
|
020 |
|
|
|a 0123984904
|q (electronic bk.)
|
020 |
|
|
|a 0123979331
|
020 |
|
|
|a 9780123979339
|
020 |
|
|
|z 9780123979339
|
035 |
|
|
|a (OCoLC)893332893
|
050 |
|
4 |
|a QR185.6
|
060 |
|
4 |
|a Online Book
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.07
|a 616.0798
|
245 |
0 |
0 |
|a Molecular biology of B cells /
|c edited by Frederick W. Alt, Tasuku Honjo, Andreas Radbruch, Michael Reth.
|
250 |
|
|
|a 2nd edition.
|
264 |
|
1 |
|a London :
|b Elsevier Science,
|c 2015.
|
300 |
|
|
|a 1 online resource (xxiii 563 pages) :
|b color illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed on November 6, 2014).
|
520 |
|
|
|a Molecular Biology of B Cells, Second Edition is a comprehensive reference to how B cells are generated, selected, activated and engaged in antibody production. All of these developmental and stimulatory processes are described in molecular, immunological, and genetic terms to give a clear understanding of complex phenotypes. Molecular Biology of B Cells, Second Edition offers an integrated view of all aspects of B cells to produce a normal immune response as a constant, and the molecular basis of numerous diseases due to B cell abnormality. The new edition continues its success with update.
|
505 |
0 |
|
|a Front Cover; Molecular Biology of B Cells; Copyright; Dedication; Contents; Preface; Contributors; Chapter 1 -- The Structure and Regulation of the Immunoglobulin Loci; 1. INTRODUCTION; 2. GENOMIC ORGANIZATION OF THE MOUSE IMMUNOGLOBULIN HEAVY CHAIN LOCUS; 3. GENOMIC ORGANIZATION OF THE MOUSE IMMUNOGLOBULIN KAPPA LIGHT CHAIN LOCUS; 4. GENOMIC ORGANIZATION OF THE MOUSE IMMUNOGLOBULIN LAMBDA LIGHT CHAIN LOCUS; 5. B CELL DEVELOPMENT AND REGULATION OF V(D)J RECOMBINATION; 6. JUNCTIONAL DIVERSITY; 7. COMBINATORIAL DIVERSITY; 8. NONCODING TRANSCRIPTION AND IMMUNOGLOBULIN LOCUS REARRANGEMENT.
|
505 |
8 |
|
|a 9. THE PROCESS OF DH-JH RECOMBINATION10. EPIGENETICS AND IMMUNOGLOBULIN LOCUS REARRANGEMENT; 11. INSULATORS AND IMMUNOGLOBULIN LOCUS REARRANGEMENT; 12. 3D STRUCTURE AND COMPACTION OF THE IMMUNOGLOBULIN HEAVY CHAIN LOCUS; 13. CONCLUSION; REFERENCES; Chapter 2 -- The Mechanism of V(D)J Recombination; 1. OVERVIEW; 2. ANTIGEN RECEPTOR GENE ASSEMBLY; 3. RECOMBINATION SIGNAL SEQUENCES; 4. BIOCHEMISTRY OF V(D)J CLEAVAGE; 5. RAG1 AND RAG2; 6. A ROLE FOR HMGB1 IN V(D)J RECOMBINATION; 7. RECOMBINATION COMPLEXES: ANALYSIS OF STOICHIOMETRY AND ORGANIZATION.
|
505 |
8 |
|
|a 8. V(D)J RECOMBINATION IS TIGHTLY REGULATED DURING LYMPHOCYTE DEVELOPMENT9. ACCESSIBILITY MODEL OF REGULATION; 10. OVERVIEW OF CHROMATIN STRUCTURE; 11. REGULATION BY NUCLEOSOME STRUCTURE AND HISTONE ACETYLATION; 12. REGULATION BY HISTONE METHYLATION; 13. HOW IS THE CHROMATIN STRUCTURE OF ANTIGEN RECEPTOR LOCI DEVELOPMENTALLY REGULATED?; 14. ADDITIONAL LAYERS OF REGULATION; 15. REGULATION OF V(D)J RECOMBINATION: SUMMARY; 16. ONCOGENIC LESIONS IN LYMPHOID NEOPLASMS: THE PRICE OF A DIVERSE ANTIGEN RECEPTOR REPERTOIRE; 17. PROPOSED MECHANISMS UNDERLYING RAG-MEDIATED GENOMIC LESIONS.
|
505 |
8 |
|
|a 18. REGULATORY CONTROLS PROPOSED TO SUPPRESS RAG-MEDIATED GENOMIC INSTABILITY19. V(D)J RECOMBINATION ERRORS AS PATHOGENIC LESIONS IN LYMPHOID NEOPLASMS: SUMMARY; REFERENCES; Chapter 3 -- Transcriptional Regulation of Early B Cell Development; 1. PU. 1 SETS THE STAGE FOR LYMPHOID AND MYELOID DEVELOPMENT; 2. LINEAGE PRIMING IN LYMPHOID PROGENITORS BY IKAROS; 3. E2A REGULATES THE CHROMATIN LANDSCAPE TO PROMOTE GENE EXPRESSION IN B CELL DEVELOPMENT; 4. E2A IS INHIBITED BY ID PROTEINS; 5. INTERLEUKIN-7/STAT5 SIGNALING PROVIDES AN EARLY SIGNAL FOR B CELL LINEAGE SPECIFICATION.
|
505 |
8 |
|
|a 6. EARLY B CELL FACTOR: CENTRAL COORDINATOR OF B CELL DEVELOPMENT7. COLLABORATION BETWEEN EBF1 AND FOXO1; 8. REGULATION OF THE B CELL-SPECIFIC PROGRAM BY PAX5; 9. REGULATION OF B LINEAGE COMMITMENT; 10. CONCLUSION; ACKNOWLEDGMENT; REFERENCES; Chapter 4 -- Relationships among B Cell Populations Revealed by Global Gene Analysis; 1. INTRODUCTION; 2. GENE PROFILE CHANGES WITH B CELL MATURATION SUGGEST AN ORDERING OF TRANSITIONAL STAGES; 3. DISTINCTIONS IN GENE NETWORKS ACTIVATED IN MATURE B CELL POPULATIONS.
|
650 |
|
0 |
|a Molecular immunology.
|
650 |
|
0 |
|a B cells.
|
650 |
|
0 |
|a B cells
|x Differentiation
|x Molecular aspects.
|
650 |
|
0 |
|a Immunoglobulins.
|
650 |
|
0 |
|a Immunoglobulin genes.
|
650 |
1 |
2 |
|a B-Lymphocytes
|0 (DNLM)D001402
|
650 |
1 |
2 |
|a Immunoglobulins
|0 (DNLM)D007136
|
650 |
|
2 |
|a Genes, Immunoglobulin
|0 (DNLM)D005803
|
650 |
2 |
2 |
|a Cell Differentiation
|x physiology
|0 (DNLM)D002454Q000502
|
650 |
|
6 |
|a Immunologie mol�eculaire.
|0 (CaQQLa)201-0203813
|
650 |
|
6 |
|a Lymphocytes B.
|0 (CaQQLa)201-0056955
|
650 |
|
6 |
|a Lymphocytes B
|x Diff�erenciation
|x Aspect mol�eculaire.
|0 (CaQQLa)201-0207818
|
650 |
|
6 |
|a G�enes de l'immunoglobuline.
|0 (CaQQLa)201-0276999
|
650 |
|
6 |
|a Immunoglobulines.
|0 (CaQQLa)201-0008346
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a B cells
|2 fast
|0 (OCoLC)fst00824789
|
650 |
|
7 |
|a B cells
|x Differentiation
|x Molecular aspects
|2 fast
|0 (OCoLC)fst00824791
|
650 |
|
7 |
|a Immunoglobulin genes
|2 fast
|0 (OCoLC)fst00967959
|
650 |
|
7 |
|a Immunoglobulins
|2 fast
|0 (OCoLC)fst00967961
|
650 |
|
7 |
|a Molecular immunology
|2 fast
|0 (OCoLC)fst01024811
|
700 |
1 |
|
|a Honj�o, Tasuku,
|e editor.
|
700 |
1 |
|
|a Reth, Michael,
|e editor.
|
700 |
1 |
|
|a Radbruch, A.
|q (Andreas),
|e editor.
|
700 |
1 |
|
|a Alt, Frederick W.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Molecular biology of B cells.
|d Boston, Massachusetts : Elsevier, [2015]
|z 9780123979339
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780123979339
|z Texto completo
|